A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

The combination of irinotecan (CPT-11), oxaliplatin (L-OHP), 5-fluorouracil (5-FU) and folinic acid (FA) is one of the possibilities to overcome chemoresistance in advanced colorectal cancer (ACRC) patients. The aim of this study was to determine the tolerability and activity of CPT-11 plus chronomo...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Garufi, C, Bria, E, Vanni, B, Zappalà, A M R, Sperduti, I, Terzoli, E
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group 2003
Ämnen:
Clinical
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2394458/
https://ncbi.nlm.nih.gov/pubmed/14612895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601382
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk